Because of an impurity in Zantac or other ranitidine products, use of the medication for a significant period of time could lead to intestinal cancer, colorectal cancer, and other primary cancers. This is because a probable human carcinogen was discovered in the medication.
If you took Zantac for months or years, and later developed intestinal or colorectal cancer, then you can file a lawsuit against Zantac manufacturers. Get started with your lawsuit by contacting us today, or learn more about intestinal cancer and why Zantac may cause it.
Symptoms Of Intestinal Cancer
Intestinal cancer refers to when cancerous cells develop in the small intestine, which is also called the small bowel. Small intestine cancer is rarer than other cancers of the gastrointestinal system.
The small intestine is part of the digestive system. Your small intestine is a long, tube-like organ that connects the large intestine with the stomach. If cancer develops in your large intestine, it’s known as colorectal cancer.
Symptoms of intestinal cancer include:
- abdominal pain
- unexplained weight loss
- blood in the stool
- lump in abdomen
- abdomen pain or discomfort
There are five types of small intestine cancer, including adenocarcinoma, sarcoma, carcinoid tumors, gastrointestinal stromal tumor, and lymphoma. Although diet and health history can affect the risk of developing small intestine cancer, so can taking Zantac or other ranitidine products for long periods of time.
Zantac And The Risk For Intestinal Cancer
Zantac is no longer available in the United States. In April 2020, the FDA issued a statement that urged all ranitidine manufacturers to remove the medication from the market. The federal agency discovered that ranitidine can develop a cancer-causing chemical when stored at high temperatures for extended periods of time.
This probable human carcinogen—N-nitrosodimethylamine (NDMA), is now associated with Zantac use and a risk for cancer in humans. The cancer risk in humans stems from research that showed high exposure to NDMA causes cancer in animals.
According to the Environmental Protection Agency (EPA), lab animals exposed to NDMA developed cancerous tumors in various organs, including in the liver and respiratory tract. Similar studies also identified an increased risk for gastrointestinal tumors after exposure to NDMA.
While there is no direct evidence between NDMA and cancer in humans, the assumption is that repeated exposure to the chemical can increase cancer risk.
When Was NDMA Discovered In Zantac?
The online pharmacy Valisure first discovered the presence of NDMA in ranitidine in 2019. By 2020, the FDA acknowledged that NDMA can develop in the medication. As a result, both prescription and over-the-counter ranitidine products are unavailable.
Due to the popularity of Zantac since the early 1980s, thousands of people are potentially affected and have grounds for filing a lawsuit.
For example, one plaintiff who was diagnosed with colon cancer after taking Zantac filed a lawsuit against ranitidine manufacturers. The lawyers in this case argue that ranitidine molecules are inherently unstable and break down into NDMA once it enters the digestive system.
Our Featured Case Results
What To Know About Zantac Lawsuits
If you developed intestinal cancer, or any other form of cancer, after taking Zantac, you can file a lawsuit. As of May 2020, there are roughly 230 lawsuits that have been filed against Zantac manufacturers. At least 15 Zantac-related cases have been consolidated into what’s called multidistrict litigation (MDL) in a Florida court.
The reason for an MDL is to allow thousands of plaintiffs to file Zantac-related lawsuits. There are already several cases in this Zantac-related MDL, and many more are expected throughout 2020.
What Zantac Lawsuits Allege
Zantac lawsuits allege that companies who manufactured or sold Zantac were aware that ranitidine, the active ingredient in the medication, can metabolize in the human body to form NDMA. The Zantac lawsuits include both personal injury claims and class action suits.
While personal injury claims can go after noneconomic damages like pain and suffering, class action lawsuits can only recover damages for the money spent on the medication.
If you want to hold manufacturers responsible for selling a potentially cancer-causing medication, then you’re likely better off filing a personal injury claim against the liable pharmaceutical companies.
The major defendants in current Zantac lawsuits include:
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Pfizer, Inc.
Because Zantac has been on the market since 1983, many people may have developed cancer, whether intestinal cancer or other forms, without knowing that Zantac may have played a role.
We Are Nationally Awarded Lawyers
File A Zantac Cancer Lawsuit
If there was a risk that taking Zantac or other ranitidine products could lead to cancer, you likely would have looked for other options. The medication you took should have been safe, and filing a lawsuit can help you recover damages and hold manufacturers accountable.
Florin|Roebig offers free case evaluations to better assess where you stand with a lawsuit. To learn more about Zantac lawsuits, or to submit a free case evaluation, please contact us today.